戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 hondrial function and longevity, by reducing protein kinase C-beta.
2  is increased after PMA-evoked activation of protein kinase C-beta.
3 ding those for annexin VI, interleukin-4 and protein kinase C-beta.
4  between PKCI-1 and the regulatory domain of protein kinase C-beta.
5 able transfection of expression plasmids for protein kinases C beta 1 (PKC beta 1) or PKC beta 2 into
6 lted in a preferential decrease in epidermal protein kinase C-beta 2 (PKC-beta 2) compared with PKC-a
7          We further identify a BAFF-specific protein kinase C beta-Akt signaling axis, which provides
8 tagged lipid-binding proteins such as epsin, protein kinase C-beta, and synaptobrevin.
9 x, including synaptotagmin I, cAMP-dependent protein kinase C beta, apolipoprotein E, protein phospha
10                      A specific inhibitor of protein kinase C-beta blocked the substrate-mediated inc
11  a mechanism dependent on SNARE proteins and protein kinase C-beta but independent of dopamine D(2) r
12 binding to C2 domains of synaptotagmin I and protein kinase C-beta by nuclear magnetic resonance spec
13   Among the protein knase C isoforms tested, protein kinase C beta, delta, and epsilon were most effe
14 Haploinsufficiency or complete deficiency of protein kinase C beta, Fyn, CD22, Galphaq, or Galpha11 h
15  the Src-family protein tyrosine kinase Lyn, protein kinase C beta I/II (PKCbetaI/II), and Erk2-speci
16                       Elevated expression of protein kinase C beta II (PKC beta II) is an early promo
17 the unphosphorylated turn motif (Thr(641) in protein kinase C beta II), one of three priming sites ph
18 tion of the interaction with Hsp70 slows the protein kinase C beta II-mediated recovery of cells from
19 irect binding of this class of activators to protein kinase C beta II.
20           Using homozygous null mice for the protein kinase C beta-isoform gene (PKCbeta null), PKCbe
21 trast, treatment with D-alpha-tocopherol and protein kinase-C beta-isoform inhibition (LY333531) prev
22 ds induced by diabetes mellitus can activate protein kinase C-beta isoforms and selectively inhibit i
23                       Abnormal activation of protein kinase C-beta isoforms in the diabetic state has
24 ling, but GC cells signaled less through the protein kinase C-beta-NF-kappaB pathway and produced str
25    Using the HL-60 cell variant deficient in protein kinase C-beta (PKC-beta) and several stable PKC-
26                                  The role of protein kinase C-beta (PKC-beta) in apoptosis induced by
27 AI-1 induction was suppressed by a selective protein kinase C-beta (PKC-beta) inhibitor.
28                                              Protein kinase C-beta (PKC-beta) is immediately downstre
29                We have previously shown that protein kinase C-beta (PKC-beta) is required for activat
30 osolic phospholipase A2-alpha (cPLA2-alpha), protein kinase C-beta (PKC-beta), and synaptotagmin-IA (
31                                 B cells from protein kinase C-beta (PKC-beta)-deficient mice failed t
32                           We have identified protein kinase C beta (PKCbeta) as a critical mediator o
33  we identify the calcium-regulated classical protein kinase C beta (PKCbeta) as a repressor of myogen
34 the recommended dose of enzastaurin, an oral protein kinase C beta (PKCbeta) inhibitor, for phase II
35                                              Protein kinase C beta (PKCbeta) participates in antigen-
36                                              Protein kinase C beta (PKCbeta) regulated MIF-induced IL
37                                              Protein kinase C beta (PKCbeta) was identified by gene-e
38                     Using mice deficient for protein kinase C beta (PKCbeta) we show an essential rol
39         One key mediator of BCR signaling is protein kinase C beta (PKCbeta), which regulates the act
40 d that combined small-molecule inhibition of protein kinase C-beta (PKCbeta) and glycogen synthase ki
41 l insulin signaling, through the activity of protein kinase C-beta (PKCbeta) and nuclear factor kappa
42             While targeted disruption of the protein kinase C-beta (PKCbeta) gene in mice results in

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。